Heidelberg Pharma AG
XETRA:HPHA

Watchlist Manager
Heidelberg Pharma AG Logo
Heidelberg Pharma AG
XETRA:HPHA
Watchlist
Price: 2.69 EUR 1.89%
Market Cap: 125.4m EUR

HPHA's latest stock split occurred on Nov 7, 2017

The company executed a 586-for-563 stock split, meaning that for every 563 shares held, investors received 586 new shares.

Before the split, HPHA traded at 2.947 per share. Afterward, the share price was about 2.802.

The adjusted shares began trading on Nov 7, 2017. This was HPHA's 9th stock split, following the previous one in Apr 26, 2017.

Last Splits:
Nov 7, 2017
586-for-563
Apr 26, 2017
698-for-697
Apr 8, 2016
277-for-276
Mar 20, 2015
83-for-82
Jul 18, 2014
1-for-4
Pre-Split Price
2.8313 2.947
Post-Split Price
2.802
Before
After
Last Splits:
Nov 7, 2017
586-for-563
Apr 26, 2017
698-for-697
Apr 8, 2016
277-for-276
Mar 20, 2015
83-for-82
Jul 18, 2014
1-for-4

Heidelberg Pharma AG
Stock Splits History

HPHA Stock Splits Timeline
Nov 7, 2017
Nov 7, 2017
Split 586-for-563
x1.0408525754885
Pre-Split Price
2.8313 2.947
Post-Split Price
2.802
Before
After
Apr 26, 2017
Apr 26, 2017
Split 698-for-697
x1.0014347202296
Pre-Split Price
2.3754 2.476
Post-Split Price
2.4499
Before
After
Apr 8, 2016
Apr 8, 2016
Split 277-for-276
x1.0036231884058
Pre-Split Price
1.7962 1.8791
Post-Split Price
1.7461
Before
After
Mar 20, 2015
Mar 20, 2015
Split 83-for-82
x1.0121951219512
Pre-Split Price
2.8596 3.028
Post-Split Price
2.8171
Before
After
Jul 18, 2014
Jul 18, 2014
Split 1-for-4
/0.25
Pre-Split Price
3.0334 0.8029
Post-Split Price
2.938
Before
After
Aug 8, 2012
Aug 8, 2012
Split 1373-for-1369
x1.0029218407597
Pre-Split Price
14.1284 3.751
Post-Split Price
14.5021
Before
After
Jan 17, 2012
Jan 17, 2012
Split 1333-for-1316
x1.0129179331307
Pre-Split Price
N/A
Post-Split Price
14.1247
Before
After
Jul 21, 2010
Jul 21, 2010
Split 1679-for-1648
x1.0188106796117
Pre-Split Price
N/A
Post-Split Price
14.1247
Before
After
Nov 16, 2009
Nov 16, 2009
Split 620-for-521
x1.190019193858
Pre-Split Price
N/A
Post-Split Price
14.1247
Before
After

Global
Stock Splits Monitor

Date Company Split Pre-Split Price Post-Split Price
Mar 25, 2025
CMC Metals Ltd
XTSX:CMB
1-for-10
/10
0.02 0.2 CAD 0.25 0.25 CAD
Mar 25, 2025
Rent.com.au Ltd
ASX:RNT
63-for-62
x1.0161290322581
0.021 0.0207 AUD 0.018 0.018 AUD
Mar 25, 2025
U
US Critical Metals Corp
OTC:USCMF
1-for-2
/2
0.06 0.15 USD 0.1127 0.1127 USD
Mar 25, 2025
Xcel Brands Inc
NASDAQ:XELB
1-for-10
/10
0.3847 3.847 USD 4.35 4.35 USD
Mar 25, 2025
CMC Metals Ltd
F:ZM5P
1-for-10
/10
0.0038 0.038 EUR 0.009 0.009 EUR
Load More

Heidelberg Pharma AG
Glance View

Market Cap
125.4m EUR
Industry
Biotechnology

Heidelberg Pharma AG is a biopharmaceutical company, which engages in the research and development of drugs for cancer patients. The company is headquartered in Ladenburg, Baden-Wuerttemberg and currently employs 89 full-time employees. The company went IPO on 2006-11-13. The firm focuses on the research and development of therapy treatments for oncology area. The company aims at applying toxin Amanitin into cancer therapies using its Antibody Targeted Amanitin Conjugate (ATAC) technology. The Company’s pipeline includes a number of drug candidates, such as HDP-101, a B-cell maturation antigen ATAC for multiple myeloma; PSMA-ATAC, prostate-specific membrane antigens, and CD19-ATAC, a B-lymphocyte antigen. Through partnerships, the Company develops clinical assets, including MESUPRON, REDECTANE and RENCAREX. The company also offers preclinical contract research services.

HPHA Intrinsic Value
2.8 EUR
Undervaluation 4%
Intrinsic Value
Price
What is Intrinsic Value?
Back to Top
ALPHA SPREAD
Follow us
Join more than 241,500+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.